Financial benefits, faster approvals and less stringent clinical data requirements are some important benefits that regulatory agencies across the world offer as incentives for development of orphan drugs for rare diseases. These countries include the US, Europe, Japan, Australia, South Korea, Brazil and most recently, India. These incentives have been so supportive and convincingly helpful […]

Read More →

Thailand is the second largest healthcare market in Southeast Asia after Indonesia making up roughly about 20% of the region’s expenditure. Thailand’s pharmaceutical market is the eight largest in the Asia Pacific region and considered as one of the largest and most developed in ASEAN. Why choose Thailand as your Generic Drug Market? Thailand’s Generic market presents […]

Read More →

Exploring the region that conducts most clinical trials in the world and is the flag bearer for most clinical research studies, requires considering many factors and areas. In first part of this series of article for Clinical Trials in United States, regulatory situation, site and investigators were discussed. In this part, we will be knowing about […]

Read More →

The United States has consistently emerged as a leading site for clinical research. Clinicaltrials.gov registry, which serves as an effective reference to see clinical trials conducted worldwide, provides an interesting statistics regarding U.S. clinical trials. Clinical trials statistics in the U.S. A glimpse into the studies registered between 2011 and 2013 and further between 2014 […]

Read More →

Taiwan is emerging as a big player in the Asian clinical trial market. There are many advantages of conducting clinical trials in Taiwan, which have been discussed in Part 1 of this blog. In this part, let’s talk a bit on the clinical trial regulatory scenario in Taiwan, including the approvals required and how to be prepared […]

Read More →

Recently, Thailand FDA has brought a revised list of institutional review boards (IRBs) / ethics committees (ECs) that it recognizes for acceptance of applications. In our previous articles (see Part I and Part II), we’ve discussed about the regulatory scenario in Thailand, including regulatory approvals for clinical trial in Thailand, ethics committee approval for clinical trial in Thailand, […]

Read More →

Taiwan has one of the most progressive healthcare systems in the world and is a major hub for clinical research in the Asia-Pacific region. Currently, it is well positioned to meet the growing demands of the global clinical trial market. Why choose Taiwan There are many good reasons to go to Taiwan for clinical trials. Here are […]

Read More →